Newsroom

Bristol-Myers Squibb and Moffitt Cancer Center Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program 9.30.15

September 25, 2015  NEW YORK & TAMPA, Fla.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Moffitt Cancer Center today announced that they have entered into a collaboration agreement as part of Bristol-Myers Squibb's Immuno-Oncology Rare Population Malignancy (I-O RPM) program in...

Florida Institute Funds Orlando-based Aviana Molecular Technologies 9.24.15

Gainesville and Boca Raton, FL., Sept. 24, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Aviana Molecular Technologies (AMT), an Orlando-based company with technology developed at the ...

Florida Institute Funds Medical Technology Company MYOLYN 9.15.15

Gainesville and Boca Raton, FL, Sept. 15, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with MYOLYN, a Gainesville-based company with technology licensed from the University of Florida. MYOLYN is...

Exciting News From The Florida Institute 9.14.15

Building Companies, Changing Lives Issue 33- September 2015            Two Companies Receive Institute Funding   The Institute has finalized first-round funding agreements with two companies.Robotics Unlimited, Inc., a Pensacola-based company with technology licensed from the Florida...

Florida Institute Funds Pensacola-based Robotics Unlimited Inc. 9.10.15

Core Technology Licensed from the Florida Institute for Human and Machine Cognition (IHMC) GAINESVILLE and BOCA RATON, FL., Sept. 10, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Robotics...

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon